References

No references inside the corpus for this window.

Cited by

• 1998Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors147 cited
• 1993Adverse consequences of lysergic acid diethylamide140 cited
• 1995The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis136 cited
• 2001Brain mechanisms of hallucinogens and entactogens130 cited
• 1996Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans130 cited
• 2016d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology124 cited
• 2016Serotonergic Hallucinogen-Induced Visual Perceptual Alterations112 cited
• 1996Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups107 cited
• 1997Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives90 cited
• 1999Do hallucinogens cause residual neuropsychological toxicity?82 cited
• 2007Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane78 cited
• 1995Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium76 cited
• 2013Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function